Prediction of trastuzumab benefit in HER2-positive breast cancers: Is it in the intrinsic subtype? Journal Article

  

Authors:	Kim, J.; Pareja, F.; Weigelt, B.; Reis-Filho, J. S.
Article Title:	Prediction of trastuzumab benefit in HER2-positive breast cancers: Is it in the intrinsic subtype?
Journal Title:	JNCI: Journal of the National Cancer Institute
Volume:	109
Issue:	2
ISSN:	0027-8874
Publisher:	Oxford University Press
Date Published:	2017-02-01
Start Page:	djw218
Language:	English
DOI:	10.1093/jnci/djw218
PROVIDER:	scopus
PUBMED:	27794126
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018663866&doi=10.1093%2fjnci%2fdjw218&partnerID=40&md5=fd98028f904fd96e6da6852f4e88ca64
Notes:	Editorial -- Export Date: 2 June 2017 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/110465